Iron Overload Prevention
Iron Overload Prevention - Related Videos
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
0 Views •
Cited by 4 •
2017
We have outlined a method of continuous manual exchange transfusion for the treatment of sickle cell disease in patients. This safe protocol was designed to effectively limit iron overload in patients in need of chronic transfusions and can be used extensively without any special equipment.
08:45
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
0 Views •
Cited by 3 •
2022
This article demonstrates how to prepare and administer transferrin-bound nonradioactive isotopic iron for studies of iron transport in mouse pregnancy. The approach for quantifying isotopic iron in fetoplacental compartments is also described.
03:06
Culturing Mycobacterium tuberculosis Under Iron-Limited Conditions
0 Views •
2025
Source: Gupta, S., et al. Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria. J. Vis. Exp. (2019)This video demonstrates the procedure for culturing Mycobacterium tuberculosis under iron-limited conditions to induce iron stress and promote the secretion of siderophores that support bacterial survival.
06:52
Experimental Column Setup for Studying Anaerobic Biogeochemical Interactions Between Iron (Oxy)Hydroxides, Trace Elements, and Bacteria
0 Views •
Cited by 3 •
2017
Fate and speciation of arsenic and mercury in aquifers are closely related to physio-chemical conditions and microbial activity. Here, we present an original experimental column setup that mimics an aquifer and enables a better understanding of trace element biogeochemistry in anoxic conditions. Two examples are presented, combining geochemical and microbiological approaches.
06:37
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
0 Views •
Cited by 31 •
2013
Here we describe a growth assay for Staphylococcus aureus using hemoglobin as the sole source of available nutrient iron. This assay establishes the role of bacterial factors involved in hemoglobin-derived iron acquisition.
FAQs
Hepcidin, a hormone produced by the liver, helps regulate how much iron the body absorbs. When this control is disrupted, iron accumulation can increase, particularly in hereditary hemochromatosis. Understanding this regulatory pathway helps clinicians identify why some people require closer monitoring and why prevention may focus on limiting additional iron exposure or intervening before organ injury develops.
These situations can increase iron burden through different pathways. Hereditary hemochromatosis can disturb normal iron regulation, repeated blood transfusions can progressively add iron, and unnecessary iron products can provide iron without a medical need. Distinguishing the underlying risk helps clinicians choose appropriate monitoring and determine whether preventive treatment should be considered.
Clinicians use serum ferritin and transferrin saturation to assess the risk of excessive iron accumulation. These tests help identify people who may need closer evaluation, especially when hereditary or transfusion-related risks are present. Their role is preventive as well as diagnostic because recognizing a concerning pattern can support earlier intervention before tissue deposition produces serious complications.
People with hereditary hemochromatosis or a history of repeated blood transfusions may require scheduled assessment because their risk of iron accumulation is increased. Clinicians may also review iron use in people taking supplements without a clear need. Monitoring with serum ferritin and transferrin saturation helps guide timely decisions about observation or treatment.
Scheduled phlebotomy or iron-chelating therapy may be used when clinical assessment shows that intervention is needed to control iron accumulation. Phlebotomy removes blood on a planned schedule, while chelating therapy addresses excess iron through medication. The choice depends on the clinical situation, and these approaches are used to reduce tissue deposition and limit organ damage.
Controlling iron accumulation can reduce deposition in organs that are especially vulnerable, including the liver, heart, and pancreas. Earlier prevention or treatment may therefore help lower the risk of cirrhosis, cardiomyopathy, diabetes, and other complications. This makes risk assessment important even before symptoms or irreversible organ injury become evident.